3 Stocks Hitting Low Notes
By
Motley Fool Staff
November 9, 2009
|
When a stock hits a fresh low, it can either signal a dirt cheap dream stock or a dreadful stock to avoid. Separating the wheat from the chaff is difficult, but finding well-run companies at bargain-basement prices is a great way to accumulate a fortune over the long run.
With that in mind, we'll use the aggregate intelligence of the 140,000-plus investors participating in Motley Fool CAPS to see what the community is saying about stocks hitting 52-week lows today. The community's approval (signified by four- and five-star ratings) could indicate that further research is in order.
Here are three such stocks:
| Company |
Today’s Intraday Price
|
Industry
|
CAPS Rating (out of 5)
|
Fools Saying Outperform
|
|
UltraShort FTSE/Xinhua China 25 ProShares (NYSE: FXP)
|
$7.54
|
Dedicated Short Bias Funds
|
|
397 of 541
|
|
Myriad Genetics, Inc. (Nasdaq: MYGN)
|
$22.98
|
Biotechnology
|
|
410 of 438
|
|
Apollo Group, Inc. (Nasdaq: APOL)
|
$55.15
|
Diversified Consumer Services
|
|
662 of 788
|
Source: Motley Fool CAPS, as of November 9, 2009
Top-rated dedicated short bias funds companies:
-
ProShares UltraShort Lehman 20+Year Treasury (NYSE: TBT): Stock price is 23% lower than last year.
Top-rated biotechnology companies:
-
ImmunoGen, Inc. (Nasdaq: IMGN): Stock price is 92% higher than last year.
-
3SBio, Inc. (ADR) (Nasdaq: SSRX): Stock price is 90% higher than last year.
Join us on CAPS to learn more about these and countless other interesting stock ideas.
Like this article? Get our best articles delivered direct to your inbox at no cost. Sign up for Foolwatch Weekly by entering your email below.